Drawing for INSMED

USPTO serial 87702890

INSMED

Reviewed by CopyMark Law Group

Reg. 5692970Status 702Registered
Filing date
Status date
Registration date
Mar 5, 2019
Examiner
WILKE, JOHN
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with INSMED?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Peter J. Willsey

Peter J. Willsey Kilpatrick Townsend & Stockton LLP701 Pennsylvania Avenue NW, Suite 200Washington, DC 20004United States

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for the treatment of pulmonary diseasesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 9, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 9, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 9, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 9, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 9, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
May 8, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 8, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 8, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 10, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 10, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 10, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 10, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 16, 2025E815TEAS SECTION 8 & 15 RECEIVED
Mar 5, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 14, 2022ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Feb 18, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 18, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 18, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 18, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 18, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 5, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 5, 2019COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 31, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 31, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 5, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 26, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 25, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 14, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE
Jan 14, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 12, 2018IUAFUSE AMENDMENT FILED
Dec 12, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 12, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 17, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 17, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 28, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 14, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 14, 2018DOCKASSIGNED TO EXAMINER
Dec 11, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 4, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance